Working… Menu

Study to Evaluate Effect of Intranasal Teriparatide on Serum P1NP, a Biomarker of Bone Formation, in Postmenopausal Women With Low Bone Mass

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01604057
Recruitment Status : Unknown
Verified May 2012 by Azelon Pharmaceuticals.
Recruitment status was:  Active, not recruiting
First Posted : May 23, 2012
Last Update Posted : May 23, 2012
Information provided by (Responsible Party):
Azelon Pharmaceuticals

No Study Results Posted on for this Study
Recruitment Status : Unknown
Estimated Primary Completion Date : July 2012
Estimated Study Completion Date : July 2012